A Khavinson bioregulator (synthetic KEDG, Lys-Glu-Asp-Gly) — the "testicular" community-marketing positioning is not supported by published KEDG literature, which actually describes anterior-pituitary-derived effects on TSH/T3/T4, thymus, and immunity.
Testagen (also written KEDG, sequence Lys-Glu-Asp-Gly) is a synthetic tetrapeptide from the Khavinson bioregulator family. Honest framing note: the “testicular bioregulator” / “male endocrine support” positioning that circulates in vendor copy is not supported by the PubMed-indexed literature on KEDG. The published Khavinson-group papers (PMIDs 19024016, 20731122, 21809626, 22268052, 23658898) describe KEDG as derived from anterior pituitary cytomedin amino-acid composition, with measured downstream effects on TSH/T3/T4 normalization, thyroid morphology, thymus recovery, immunity, and hemostasis — none of those papers measure testosterone, Leydig cells, Sertoli cells, or spermatogenesis.
Unlike testosterone replacement therapy (TRT), Testagen is not a hormone and does not deliver androgens. It is also not interchangeable with Epitalon (Ala-Glu-Asp-Gly) — the only Khavinson tetrapeptide with the prefix “testicular” in the title (PMID 19110597) is actually about Epitalon, not KEDG. Vendor copy that conflates the two is a recurring source of audit-flagged claims.
Not FDA approved. Sold in Russia as a “biologically active dietary supplement” (БАД) — not a registered Russian pharmaceutical. Not specifically listed on the WADA prohibited list, though the S0 catch-all may apply. Available as oral capsule or injectable.
The published KEDG literature describes effects on TSH/T3/T4 normalization, thyroid morphology, thymus recovery, immunity, and hemostasis (Khavinson group, PMIDs 19024016, 20731122, 22268052, 23658898). Testicular / Leydig / Sertoli / spermatogenesis effects are not measured in any peer-reviewed KEDG paper.
Testagen does not supply exogenous testosterone or any other androgen. It is not a hormone-replacement product. Vendor-marketing positioning as a "natural T booster" or "endogenous testosterone support" is not anchored in the published KEDG literature.
Marketed as an age-management tool in Russian community/clinical practice. Note that the published KEDG findings are pituitary/thyroid/immunity-focused, not testicular function — the "age-related testicular decline" positioning is community-marketing extrapolation, not a finding from the KEDG papers.
Research is primarily Russian cohort data. Not widely replicated in Western RCT settings. Expect modest, slowly-accumulating effects rather than TRT-level changes.
| Benefit | Evidence |
|---|---|
| Thyroid (TSH / T3 / T4) | Khavinson-group reports of TSH/T3/T4 normalization and thyroid morphology improvements (PMIDs 19024016, 20731122). The published KEDG-specific effect cluster. |
| Thymus / immunity | Reported thymus recovery and immune-modulating effects in Khavinson-lineage work (PMIDs 22268052, 23658898). |
| Hemostasis | Reported effects on hemostasis parameters in Khavinson-group work. |
| Testosterone / libido / spermatogenesis | Not measured in any published KEDG paper. Vendor-marketing claims for testosterone support, libido, or spermatogenesis are extrapolation from community framing, not findings from the peer-reviewed KEDG literature. |
Build your protocol, log every dose, monitor your body's response, and get reminders so you never miss a dose.
Start Tracking FreeIf you have clinically low testosterone (<300 ng/dL with symptoms), discuss TRT with a qualified provider. Testagen is not a substitute for TRT — it’s a maintenance tool for men with adequate-but-declining function.
Most commonly supplied as oral capsules — no reconstitution needed. For injectable powder, reconstitute same as Cartalax (see Cartalax guide).
Pre-filled with a typical Testagen setup. Edit any field — the draw updates live.
Insulin syringe — 100 units = 1 mL
Free account. Saves your reconstitution + schedules doses + tracks every vial.
Dosing cheat sheet, reconstitution reference, and cycle planning — delivered to your inbox.
Clean safety profile — no hormonal-replacement-type side effects since Testagen doesn’t directly supply androgens.
Looking for Testagen? We recommend NextGen Peptides — third-party tested, fast shipping, and trusted by the StackTrax community.
10% off with code
Exclusive StackTrax discount
Build your protocol, log every dose, monitor your body's response, and get reminders so you never miss a dose.
Start Tracking FreeTestagen (also written KEDG, sequence Lys-Glu-Asp-Gly) is a synthetic tetrapeptide from the Khavinson bioregulator family. The testicular bioregulator and male endocrine support positioning that circulates in vendor copy is not supported by the PubMed-indexed literature on KEDG. The published Khavinson-group papers (PMIDs 19024016, 20731122, 21809626, 22268052, 23658898) describe KEDG as derived from anterior pituitary cytomedin amino-acid composition, with measured downstream effects on TSH/T3/T4 normalization, thyroid morphology, thymus recovery, immunity, and hemostasis. None of those papers measure testosterone, Leydig cells, Sertoli cells, or spermatogenesis.
There is no published evidence that it does. Testosterone, libido, and spermatogenesis are not measured in any peer-reviewed KEDG paper. Testagen does not supply exogenous testosterone or any other androgen and is not a hormone-replacement product. Vendor-marketing positioning as a natural T booster or endogenous testosterone support is not anchored in the published KEDG literature. The Khavinson tetrapeptide whose published title contains the word testicular (PMID 19110597) is actually Epitalon (Ala-Glu-Asp-Gly), not KEDG, and vendor copy that conflates the two is a recurring source of audit-flagged claims.
The published KEDG-specific effect cluster is pituitary, thyroid, and immunity focused. Khavinson-group reports document TSH/T3/T4 normalization and thyroid morphology improvements (PMIDs 19024016, 20731122), thymus recovery and immune-modulating effects (PMIDs 22268052, 23658898), and reported effects on hemostasis parameters. Research is primarily Russian cohort data, not widely replicated in Western RCT settings. Expect modest, slowly-accumulating effects rather than TRT-level changes.
No. Testagen is not FDA approved. It is sold in Russia as a biologically active dietary supplement (BAD), not as a registered Russian pharmaceutical. It is not specifically listed on the WADA prohibited list, though the S0 catch-all for non-approved substances may apply. Available as oral capsule or injectable.
Standard cycle is 100 to 400 mcg/day for 10 to 20 days, run 2 to 4 cycles per year. The most common route is oral capsule, with SubQ as an alternative. Most commonly supplied as oral capsules with no reconstitution needed; for injectable powder, reconstitute the same way as Cartalax. Capsules store at room temperature protected from moisture; powder is refrigerated; reconstituted solution is refrigerated and used within 14 days.
Clean safety profile in Russian clinical use, with no hormonal-replacement-type side effects since Testagen does not directly supply androgens. Rare reports include mild GI discomfort (oral) and injection site reactions (SubQ). Do not use with active testicular or prostate cancer or prostate hyperplasia requiring active treatment. Use caution with liver disease, cardiovascular disease, and existing hormone-sensitive conditions. Not for women, children, or men under 30.
These are not interchangeable. HCG mimics LH and directly stimulates testicular testosterone and sperm production; enclomiphene blocks estrogen feedback at the hypothalamus to raise endogenous LH and FSH. Both have measured effects on the HPG axis. Testagen is not a hormone, does not bind LH receptors, and the published KEDG literature does not measure testicular function at all. If you have clinically low testosterone (under 300 ng/dL with symptoms), the conversation is TRT, HCG, or enclomiphene with a qualified provider, not Testagen.
Disclaimer: This guide is for educational and informational purposes only and is not intended as medical advice, diagnosis, or treatment. The compounds discussed are not FDA approved for human use. Always consult a qualified healthcare provider before starting any new supplement or peptide protocol. StackTrax does not sell peptides or supplements directly — purchase links go to third-party vendors. StackTrax is not responsible for the products, quality, or business practices of any third-party vendor. This page contains affiliate links — StackTrax may earn a commission on purchases at no extra cost to you.
© 2026 StackTrax, LLC. All rights reserved.
StackTrax guides cover peptides and compounds that are not FDA-approved for the uses discussed. The dosing, reconstitution, and safety information is compiled from published research and community protocols for educational purposes only.
Before using any compound mentioned here, consult a qualified healthcare provider. StackTrax does not sell, prescribe, or recommend these substances for personal use.
These pages also contain affiliate links. We may earn a commission on purchases at no extra cost to you — this never changes our editorial recommendations.